BCLSI
RPID icon

Bain Capital Life Sciences Investors’s Rapid Micro Biosystems RPID Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.1M Hold
8,434,560
– – 1.73% 14
2025
Q4 		$24.5M Hold
8,434,560
– – 1.87% 12
2025
Q3 		$28.2M Hold
8,434,560
– – 1.87% 10
2025
Q2 		$29.1M Hold
8,434,560
– – 3.64% 10
2025
Q1 		$22.3M Hold
8,434,560
– – 3.29% 9
2024
Q4 		$7.59M Hold
8,434,560
– – 0.89% 17
2024
Q3 		$7.51M Hold
8,434,560
– – 0.78% 17
2024
Q2 		$5.57M Hold
8,434,560
– – 0.61% 18
2024
Q1 		$8.18M Hold
8,434,560
– – 0.66% 21
2023
Q4 		$6.24M Hold
8,434,560
– – 0.6% 22
2023
Q3 		$9.11M Hold
8,434,560
– – 1.02% 21
2023
Q2 		$8.43M Hold
8,434,560
– – 0.87% 23
2023
Q1 		$11M Hold
8,434,560
– – 1.38% 20
2022
Q4 		$9.53M Hold
8,434,560
– – 1.07% 24
2022
Q3 		$27.2M Hold
8,434,560
– – 3.25% 10
2022
Q2 		$36.3M Hold
8,434,560
– – 4.25% 10
2022
Q1 		$57.3M Hold
8,434,560
– – 5.56% 5
2021
Q4 		$89.7M Hold
8,434,560
– – 7.12% 3
2021
Q3 		$156M Buy
+8,434,560
New +$174M 9.66% 3

Other funds holding RPID

AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
EFA
Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bain Capital Life Sciences Investors's RPID Position: Q1 2026 in Review

Bain Capital Life Sciences Investors held its Rapid Micro Biosystems (RPID) position steady in Q1 2026 at 8,434,560 shares worth $19.1M. The position accounts for 1.73% of the portfolio, ranked #14.

Bain Capital Life Sciences Investors first reported a position in RPID in Q3 2021 and has held it in 19 quarters since. The position peaked at $156M in Q3 2021. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

  • Bain Capital Life Sciences Investors held 8,434,560 shares of Rapid Micro Biosystems worth $19.1M as of Q1 2026.
  • Bain Capital Life Sciences Investors left its Rapid Micro Biosystems share count unchanged in Q1 2026.
  • Rapid Micro Biosystems made up 1.73% of Bain Capital Life Sciences Investors's portfolio in Q1 2026, its #14 holding.
  • Bain Capital Life Sciences Investors first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 19 quarters since.
  • Bain Capital Life Sciences Investors's Rapid Micro Biosystems position peaked at $156M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Bain Capital Life Sciences Investors's 13F filing for Q1 2026, filed 15 May 2026.